Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Evelo Biosciences Announces Issuance of U.S. Patent Supporting Monoclonal Microbial Oncology Trials

Evelo Biosciences 01.09.2018

Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases

Evelo Biosciences 11.16.2017

Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team

Evelo Biosciences 07.11.2017

Evelo Biosciences and Epiva Biosciences Merge to Create the Leading Immuno-Microbiome Platform Company

Evelo Biosciences 07.12.2016

Evelo Biosciences Participates in White House Office of Science and Technology Policy’s National Microbiome Initiative Event

Evelo Biosciences 05.13.2016

UChicago and Evelo Biosciences sign licensing deal for microbiome-based cancer immunotherapy

Evelo Biosciences 04.07.2016

Evelo Therapeutics Establishes Core Executive Team

Evelo Biosciences 01.11.2016

UChicago and Evelo Therapeutics Partner to Advance Microbiome-based Cancer Immunotherapy

Evelo Biosciences 11.09.2015

Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer

Evelo Biosciences 11.04.2015

Loading